BR112013014392A2 - compostos cetolídeos - Google Patents

compostos cetolídeos

Info

Publication number
BR112013014392A2
BR112013014392A2 BR112013014392A BR112013014392A BR112013014392A2 BR 112013014392 A2 BR112013014392 A2 BR 112013014392A2 BR 112013014392 A BR112013014392 A BR 112013014392A BR 112013014392 A BR112013014392 A BR 112013014392A BR 112013014392 A2 BR112013014392 A2 BR 112013014392A2
Authority
BR
Brazil
Prior art keywords
ketolide compounds
ketolide
compounds
Prior art date
Application number
BR112013014392A
Other languages
English (en)
Other versions
BR112013014392B1 (pt
Inventor
Amit Mishra
Bharat Trivedi
Deepak Dekhane
Mahesh Patel
Manish Solanki
Mohammad Jafri
Prasad Deshpande
Ravikumar Tadiparthi
Sachin Bhagwat
Santash Diwakar
Satish Bhavsar
Shivaji Pawar
Sunil Gupta
Vijay Patil
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of BR112013014392A2 publication Critical patent/BR112013014392A2/pt
Publication of BR112013014392B1 publication Critical patent/BR112013014392B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
BR112013014392-4A 2010-12-09 2011-02-03 Compostos cetolídeos, seu uso e processo de preparação, bem como composição farmacêutica compreendendo os mesmos BR112013014392B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3352MU2010 2010-12-09
IN3352/MUM/2010 2010-12-09
PCT/IB2011/050464 WO2012076989A1 (en) 2010-12-09 2011-02-03 Ketolide compounds

Publications (2)

Publication Number Publication Date
BR112013014392A2 true BR112013014392A2 (pt) 2016-07-19
BR112013014392B1 BR112013014392B1 (pt) 2021-09-21

Family

ID=54259620

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013014392-4A BR112013014392B1 (pt) 2010-12-09 2011-02-03 Compostos cetolídeos, seu uso e processo de preparação, bem como composição farmacêutica compreendendo os mesmos

Country Status (18)

Country Link
US (2) US9175031B2 (pt)
EP (2) EP2673285B1 (pt)
JP (2) JP5851516B2 (pt)
KR (1) KR101657751B1 (pt)
CN (2) CN103384676B (pt)
AU (1) AU2011340204B2 (pt)
BR (1) BR112013014392B1 (pt)
CA (2) CA2820451C (pt)
DK (1) DK2673285T3 (pt)
ES (1) ES2642287T3 (pt)
HU (1) HUE036658T2 (pt)
MX (1) MX348084B (pt)
NZ (1) NZ623574A (pt)
PL (1) PL2673285T3 (pt)
PT (1) PT2673285T (pt)
RU (1) RU2601550C2 (pt)
WO (1) WO2012076989A1 (pt)
ZA (1) ZA201304150B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ587490A (en) * 2010-08-20 2013-03-28 Greentide Ltd Anti-Microbial Compounds containing compounds with a sugar substituent
ES2603227T3 (es) * 2011-03-22 2017-02-24 Wockhardt Limited Proceso para la preparación de compuestos cetólidos
US9346828B2 (en) * 2013-06-07 2016-05-24 Wisconsin Alumni Research Foundation Forazolines, compositions thereof and uses thereof
AU2016299486B2 (en) 2015-07-27 2019-08-01 Chong Kun Dang Pharmaceutical Corp. 1,3,4-oxadiazole sulfamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
JP6559325B2 (ja) * 2015-07-27 2019-08-14 チョン クン ダン ファーマシューティカル コーポレーション ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾールアミド誘導体化合物及びこれを含有する薬剤学的組成物,
RU2697665C1 (ru) 2015-07-27 2019-08-16 Чонг Кун Данг Фармасьютикал Корп. Производные 1,3,4-оксадиазолсульфонамида в качестве ингибиторов деацетилазы гистонов 6 и фармацевтическая композиция, содержащая их
HUE057544T2 (hu) 2015-08-04 2022-05-28 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazol-származék vegyületek mint hiszton deacetiláz 6 inhibitorok, és ezeket tartalmazó gyógyszerkészítmények
US10494355B2 (en) 2015-10-12 2019-12-03 Chong Kun Dang Pharmaceutical Corp. Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
US10485812B2 (en) * 2016-01-12 2019-11-26 Wockhardt Limited Stable antibacterial composition
AU2017206672A1 (en) * 2016-01-12 2018-08-23 Wockhardt Limited Pharmaceutical compositions
EP3402487A1 (en) * 2016-01-12 2018-11-21 Wockhardt Limited Pharmaceutical compositions for the treatment of bacterial infections
WO2018167675A1 (en) * 2017-03-16 2018-09-20 Wockhardt Limited A process for preparing ketolide compounds
KR102316234B1 (ko) 2018-07-26 2021-10-22 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
AU2020380926A1 (en) * 2019-11-05 2022-05-26 Dermira, Inc. MrgprX2 antagonists and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
KR100523679B1 (ko) 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-o-치환된 케톨라이드
AU9649698A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
AU2001282105A1 (en) 2000-08-22 2002-03-04 Basilea Pharmaceutica Ag New macrolides with antibacterial activity
NZ526450A (en) 2000-12-21 2005-04-29 Pliva Istrazivacki Inst D Macrolide antibiotics
GB0031312D0 (en) 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
CN101541331A (zh) * 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
CN101855219B (zh) * 2007-09-17 2014-06-25 英安塔制药有限公司 6,11-桥联的联芳大环内酯类
WO2009137787A1 (en) * 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
MX2011012614A (es) * 2009-05-27 2012-02-22 Wockhardt Ltd Compuestos de quetolida que tienen actividad antimicrobiana.

Also Published As

Publication number Publication date
US20140005133A1 (en) 2014-01-02
CA2964104A1 (en) 2012-06-14
EP3216798A3 (en) 2017-10-25
KR101657751B1 (ko) 2016-09-19
KR20130112911A (ko) 2013-10-14
AU2011340204A1 (en) 2013-07-04
CN105669803A (zh) 2016-06-15
CN103384676A (zh) 2013-11-06
ES2642287T3 (es) 2017-11-16
DK2673285T3 (en) 2017-10-16
PL2673285T3 (pl) 2017-12-29
US20160083412A1 (en) 2016-03-24
RU2013131234A (ru) 2015-01-20
HUE036658T2 (hu) 2018-07-30
NZ623574A (en) 2015-07-31
CN103384676B (zh) 2016-02-03
CA2820451A1 (en) 2012-06-14
MX2013006461A (es) 2013-10-01
MX348084B (es) 2017-05-26
WO2012076989A1 (en) 2012-06-14
BR112013014392B1 (pt) 2021-09-21
JP5851516B2 (ja) 2016-02-03
CA2820451C (en) 2017-12-12
EP2673285B1 (en) 2017-07-19
RU2601550C2 (ru) 2016-11-10
JP2015172085A (ja) 2015-10-01
JP2013544877A (ja) 2013-12-19
PT2673285T (pt) 2017-10-19
EP3216798A2 (en) 2017-09-13
US9175031B2 (en) 2015-11-03
AU2011340204B2 (en) 2016-04-14
EP2673285A1 (en) 2013-12-18
ZA201304150B (en) 2014-11-26
JP6102991B2 (ja) 2017-03-29

Similar Documents

Publication Publication Date Title
BR112013009935C8 (pt) compostos
BR112013003753A2 (pt) compostos
BR112012028556A2 (pt) Indóis
DE102011100241A8 (de) Nitridhalbleiterbauteil
DK3225404T3 (da) Fluidpatron
DE10170954T8 (de) Mikrowellendruckgarer
DK2616465T3 (da) Triazin-oxadiazoler
DE112011104226A5 (de) Käfigmutter
BR112013014392A2 (pt) compostos cetolídeos
CO6801726A2 (es) Compuestos
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
DK2649070T3 (da) Triazolpyridinforbindelser
DE112011102080A5 (de) Kupplungszentralausrücker
DK2442899T3 (da) Rotorskive
DE102011002623A8 (de) Ventilsteuerzeitversteller
DE112011102711A5 (de) Hydrostataktor
DK2448659T3 (da) Rotorskive
DK2447426T3 (da) Vaske-WC
DE102010019119B8 (de) Cuttermesser
DE112010005518A5 (de) Dichtungsmanchette
DE102010038420A8 (de) Reinigungungsvorrichtung
DK2596072T3 (da) Bor-forbindelses-suspension
DK2521486T3 (da) Palpometer
CO6801789A2 (es) N-hetarilmetil pirazolilcarboxamidas
DE112011101796A5 (de) Redoxakkumulatoranlage

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/02/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.